SCHEMBL172796

SCHEMBL172796

O=[N+]([O-])c1cccc(CNO)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.61
MAPT P10636 3/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
POLB P06746 1/20 0.57
PTPN1 P18031 1/20 0.56
LMNA P02545 1/20 0.55
CYP19A1 P11511 1/20 0.55
ALDH1A1 P00352 4/20 0.55
CYP2C19 P33261 2/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
RECQL P46063 1/20 0.53
KDM1A O60341 2/20 0.52
MAOA P21397 2/20 0.52
MAOB P27338 2/20 0.52
KDM4E B2RXH2 1/20 0.52
TDP1 Q9NUW8 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28219453 0.82 TSHR (0.61) TSHRMAPTMEN1KMT2APOLB
SCHEMBL13219674 0.82 TSHR (0.66) TSHRMAPTMEN1KMT2APOLB
SCHEMBL28219452 0.82 TSHR (0.61) TSHRMAPTMEN1KMT2APOLB
SCHEMBL2565526 0.82 KMT2A (0.61) TSHRMAPTMEN1KMT2APOLB
SCHEMBL1829879 0.82 TSHR (0.61) TSHRMAPTMEN1KMT2APOLB
SCHEMBL4582840 0.81 PTPN1 (0.63) TSHRMAPTMEN1KMT2APOLB
Hydrochloric Acid SCHEMBL5622098 0.81 KMT2A (0.60) TSHRMAPTMEN1KMT2APOLB
SCHEMBL30482083 0.81 TSHR (0.59) TSHRMAPTMEN1KMT2APOLB
Hydrochloric Acid SCHEMBL21801320 0.81 TSHR (0.59) TSHRMAPTMEN1KMT2APOLB
SCHEMBL1039984 0.81 TSHR (0.59) TSHRMAPTMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1768966-B1 COUMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION OF BCL PROTEINS WITH BINDING PARTNERS INFINITY DISCOVERY INC (US) 2012-03-07 EP disclosed
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed
US-5563136-A ADMINISTERING FOR GASTROINTESTINAL OR NERVOUS SYSTEM DISORDERS CONNECTED WITH CHOLECYSTOKININ AND GASTRIN RHONE-POULENC RORER S.A. (FR) 1996-10-08 US disclosed